GALECTIN THERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Galectin Therapeutics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Galectin Therapeutics Inc Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 62.8M shares, a 1.48% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 62.8M +913K +1.48% Nov 8, 2024 10-Q 2024-11-14
Q2 2024 62.3M +2.7M +4.53% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 61.9M +2.46M +4.14% Feb 29, 2024 10-K 2024-03-29
Q3 2023 61.8M +2.42M +4.08% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 59.6M +186K +0.31% Aug 8, 2023 10-Q 2023-08-14
Q1 2023 59.4M +85.8K +0.15% Feb 28, 2023 10-K 2023-03-30
Q3 2022 59.4M +84.7K +0.14% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 59.4M +121K +0.2% Aug 10, 2022 10-Q 2022-08-15
Q1 2022 59.4M +2.2M +3.85% Feb 28, 2022 10-K 2022-03-31
Q3 2021 59.3M +2.26M +3.97% Nov 5, 2021 10-Q 2021-11-15
Q2 2021 59.3M +2.23M +3.91% Aug 10, 2021 10-Q 2021-08-16
Q1 2021 57.2M +127K +0.22% Feb 28, 2021 10-K 2021-03-31
Q3 2020 57.1M +191K +0.34% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 57M +412K +0.73% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 57M +11.4M +25.1% May 5, 2020 10-Q 2020-05-11
Q3 2019 56.9M +15.7M +38.3% Nov 6, 2019 10-Q 2019-11-12
Q2 2019 56.6M +15.7M +38.4% Aug 6, 2019 10-Q 2019-08-09
Q1 2019 45.6M +8.02M +21.4% May 7, 2019 10-Q 2019-05-10
Q3 2018 41.1M +5.5M +15.4% Nov 7, 2018 10-Q 2018-11-13
Q2 2018 40.9M +5.86M +16.7% Aug 8, 2018 10-Q 2018-08-14
Q1 2018 37.6M +3.51M +10.3% Mar 16, 2018 10-K 2018-03-29
Q3 2017 35.6M +6.24M +21.2% Nov 3, 2017 10-Q 2017-11-07
Q2 2017 35.1M +5.77M +19.7% Aug 7, 2017 10-Q 2017-08-14
Q1 2017 34.1M +5.24M +18.2% Mar 9, 2017 10-K 2017-03-28
Q3 2016 29.4M +5.47M +22.8% Nov 4, 2016 10-Q 2016-11-08
Q2 2016 29.3M +6.49M +28.5% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 28.8M +5.28M +22.4% Mar 10, 2016 10-K 2016-03-15
Q3 2015 23.9M +1.81M +8.16% Nov 5, 2015 10-Q 2015-11-09
Q2 2015 22.8M +745K +3.38% Aug 7, 2015 10-Q 2015-08-10
Q1 2015 23.5M +1.61M +7.36% Mar 6, 2015 10-K 2015-03-18
Q3 2014 22.1M +3.81M +20.8% Nov 7, 2014 10-Q 2014-11-10
Q2 2014 22M +5.17M +30.6% Aug 5, 2014 10-Q 2014-08-07
Q1 2014 21.9M +5.82M +36.2% Mar 19, 2014 10-K 2014-03-21
Q3 2013 18.3M +2.35M +14.7% Nov 8, 2013 10-Q 2013-11-12
Q2 2013 16.9M +1.06M +6.69% Aug 13, 2013 10-Q 2013-08-14
Q1 2013 16.1M +509K +3.26% Mar 27, 2013 10-K 2013-03-29
Q3 2012 16M -61.1M -79.3% Nov 9, 2012 10-Q 2012-11-09
Q2 2012 15.8M -58.3M -78.7% Aug 10, 2012 10-Q 2012-08-10
Q1 2012 15.6M Mar 29, 2012 10-K 2012-03-30
Q3 2011 77.1M Nov 1, 2011 10-Q 2011-11-10
Q2 2011 74.1M Aug 10, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.